XNYS · Medical Care Facilities
Last stored close · Sep 18, 2026
Close · Sep 18, 2026
$427.71-0.31%
Model Target
available with Pro
Implied upside
vs the model target
Valuation methods
the methods behind the target
TickerWhale Score
—
Not scored in the latest run — the model needs every factor family, and one was unavailable for this name.
Score components
TickerWhale View
No narrated read for this name yet — the deterministic factors still carry the analysis.
What helps
- Technical
- Valuation
What to watch
- Quality & growth
Quality & growth
30%50Moderate
- Revenue growth 7.3%
- EPS growth 25.6%
Valuation
25%58Positive
- P/E 13.9
- EV/Sales 1.8
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
#133 by market cap in our coverage · ~320,000 employees · Listed 2011-03-10 · www.hcahealthcare.com
Price history
Intraday to five-year windows are free with an account
Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.
Market intelligence
Peer position
Revenue growth (industry)Top 73%
P/E (industry)Cheaper than 82%
Technical analysis
our read · what classic indicators sayTickerWhale technical read
62/100Positive
Weighted composite of momentum, trend, relative strength, oscillators, volatility, drawdown and liquidity — not yet ranked against the universe in this run · 25% of the TickerWhale Score
Classic chart indicators
Buy
3 buy · 1 sell · 4 neutral of 8 votes
TickerWhale reads HCA's technical setup as middling at 62/100, not yet ranked against the universe in this run. Classic chart indicators lean buy, pointing the same way.
Moving averages
7 / 9constructive
- vs 200-day-4.7%
- vs 50-day+5.3%
Momentum
Mixed
- RSI (14)59 · neutral
- Stochasticsell
- CCIneutral
- Williams %Rneutral
Trend
Mixed
- ADX (14) trend strength18· weak trend
- MACD (12,26,9)buy(histogram 0.956)
How the classic verdict is reached
Moving averages (9) agree on buy — 7 buy vs 2 sell — and carry one vote between them.
Oscillators (7) vote individually: 2 buy · 1 sell · 4 neutral.
Result — 3 buy vs 1 sell of 8 votes = Buy. Neutral votes never decide the verdict.
Fundamentals & valuation
2026-09-18 · revised_latestValuation multiples
- P/E (TTM)13.9
- P/S (TTM)1.2
- P/B—
- EV/EBITDA—
- EV/Sales1.8
- PEG0.54
Profitability & returns
- Gross margin—
- Net margin8.8%
- ROE—
- Debt/Equity—
Growth
- Revenue growth (YoY)7.3%
- EPS growth (YoY)25.6%
Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.
Market capitalisation — $95.3B
Fundamentals history
Reported statement totals across recent periods.
| Metric | Dec '25 | Dec '24 | Dec '23 |
|---|---|---|---|
| Revenue | $75.6B | $70.6B | $65.0B |
| Gross profit | $31.4B | $28.7B | $25.6B |
| Operating income | $12.0B | $10.5B | $9.6B |
| Net income | $6.8B | $5.8B | $5.2B |
| EPS (diluted) | $28.33 | $22.00 | $18.97 |
| Free cash flow | $7.7B | $5.6B | $4.7B |
| Cash | $1.0B | $1.9B | $935M |
| Total debt | $48.3B | $44.9B | $41.5B |
| Equity | -$6.0B | -$2.5B | -$1.8B |
| Net debt | $47.3B | $43.0B | $40.6B |
| Debt / equity | -8.02 | -17.96 | -23.39 |
| Liabilities / assets | 1.05 | 0.99 | 0.98 |
Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.
Model Target
Model Target is a Pro feature
Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.
The Model Target is a TickerWhale Pro feature
A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.
Or see the current free one: MU →
Peers
| Company | Score | Pulse | P/E | P/E fwd | P/B | EV/Sales | Price | Chg | Estimate | Upside | Rev. gr. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HCACurrentHCA Healthcare | — | 62 | 13.9 | — | — | 1.8 | $427.71 | -0.31% | +7.3% | ||
| EXELExelixis | 81 | 80 | 17.6 | — | 8.2 | 6.1 | $58.36 | -0.22% | +9.2% | ||
| INCYIncyte | 81 | 76 | 16.2 | — | 4.1 | 3.8 | $125.31 | -1.81% | +26.9% | ||
| ACADAcadia Pharmaceuticals | 80 | 63 | 12.4 | — | 3.6 | 3.8 | $27.29 | -0.58% | +11.8% | ||
| OSCROscar Health Inc - | 78 | 67 | 19.5 | — | 5.2 | 0.5 | $32.13 | +0.47% | +43.1% | ||
| TGTXTG Therapeutics | 77 | 73 | 20.3 | — | 14.8 | 11.5 | $56.87 | +0.71% | +76.1% |
News, sentiment, the Street view and Ask Willy are free with an account
A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.